Program Details

Venue:  Michael F. Sorrell Center, Truhlsen Events Center, University of Nebraska Medical Center
Address:  619 South 42nd Street, within the Michael F. Sorrell Center for Health Science Education, on the northeast corner of 42nd and Emile streets, Omaha, NE
Parking:  Non-UNMC attendees, please park in Student Parking marked in yellow on this map.  Lots in close proximity to the Sorrell Center are 39, 21, 20 or 25.  

Thursday, June 5, 2014

Time

Speaker Topic
8:00AM - 8:20AM Group Photo and Opening Remarks:  Courtney Fletcher, Pharm.D., Dean, College of Pharmacy, UNMC
  Session Chair:  Tanya Bronich, Ph.D.
8:20AM - 9:00AM Jeffrey Hemenway, Ph.D.
Gilead Sciences
Discovery, Development and Approval of New Chemical Entities: An Overview
8:20AM - 9:00AM Danchen Gao, Ph.D.
AbbVie
Right Dosage Form to Fit Patient Better
9:40AM - 10:00AM Coffee Break   
  Session Chair:  Michael Dixon, Ph.D.
10:00AM - 10:40AM Gangadhar Sunkara, Ph.D., MBA
Novartis
Redefining Biopharmaceutical R&D: Interface between Industry and Academia for Effective Discovery & Development of Drugs 
10:40AM - 11:20AM Rod Ketner, Ph.D.
Bend Research 
Enabling Oral Drug Delivery Technologies
11:20AM - 12:00PM Roundtable Discussion Timing and Application of Enabling Technologies and Dosage Form Design During New Drug Development 
12:00PM - 1:30PM  Lunch Break
  Session Chair:  David Oupicky, Ph.D.  
1:30PM - 2:10PM Ken Waterman, Ph.D.
FreeThink Techologies, Inc. 
Accelerated Stability Assessment Program (ASAP): Using Science to Set Expiry
2:10PM - 2:50PM  Ajit Narang, Ph.D.
Bristol-Myers Squibb, Co. 
Impact of Pharmaceutical Excipients on Drug Product Stability, Bioavailability, and Manufacturability
2:50PM - 3:30PM Panos Constantinides, Ph.D.
Biopharmceutical and Drug Delivery Consulting 
Advances in Parenteral Drug Nanodispersions:  Processing, Characterization and Case Studies
3:30PM - 4:10PM Roundtable Discussion Stage appropriate stability assessment and prediction in pharmaceutical development
6:00PM Banquet hosted by Courtney Fletcher, Pharm.D., Dean, College of Pharmacy 

 
Friday, June 6, 2014 

Time Speaker Topic
  Session Chair:  Dong Wang, Ph.D. 
8:30AM - 9:10AM Ron Smith, Ph.D.
Merck
New Modalities in BioPharma
9:10AM - 9:50AM Lei Diao, Ph.D.
Biogen Idec, Inc. 
Pharmacokinetic and Pharmacodynamic Aspects of Small vs. Large Molecule Drugs
9:50AM - 10:10AM Coffee Break   
  Session Chair:  Joe Vetro, Ph.D. 
10:10AM - 10:50AM Seng Cheng, Ph.D.
Genzyme 
Research and Development of Therapies for Rare Inherited Diseases
10:50AM - 11:30AM Christine Brandquist, Ph.D.
Celerion Corporation 
PK-PD Considerations through Different Stages of Drug Development
11:30AM - 12:00PM Networking  
12:00PM - 1:00PM Lunch Break  
  Session Chair:  Jered Garrison, Ph.D. 
1:00PM - 1:40PM Colleen Rueggers, Ph.D.
Novartis 
 Global Operations and Outsourcing Considerations
1:40PM - 2:20PM Roundtable Discussion   Transitions in Drug Development:  from Discovery Research through Development and into Commercial Manufacturing
2:20PM - 2:30PM  Closing Remarks:  Ram I. Mahato, Ph.D. and Ajit Narang, Ph.D. 


;